Good News Can't Pull the Markets From the Edge of the Cliff

With the fiscal-cliff deadline looming in every investor's mind, even some truly positive economic data released today hasn't been able to help the markets move higher. The most important number released today was the revised U.S. GDP growth rate, which was raised to 3.1% during the third quarter. Additionally, the National Association of Realtors announced that total existing-home sales for November rose 6% from the previous month and were 14.5% higher than at this stage last year.

But because no real progress has been made to stop the U.S. from falling over the cliff, the Dow Jones Industrial Average (DJINDICES: ^DJI  ) is flat. As of 12:58 p.m. EST, the Dow is up just six points to 13,258 points. The majority of the Dow's 30 components are up slightly, but three of the biggest losers thus far today are Merck (NYSE: MRK  ) , Caterpillar (NYSE: CAT  ) , and Intel (NASDAQ: INTC  ) .

So why are they down?
Shares of pharmaceutical giant Merck are trading lower again today because for the second day in a row, the company has announced that a drug failed to clear certain hurdles during trials. Today that drug was Tredaptive, a cholesterol drug which had already been approved for use in Europe. Merck will no longer seek U.S. approval and is recommending that doctors abroad stop prescribing it to new patients. Merck's share price is down about 2.5% today.

Shares of Caterpillar are down by 1.1% today after the company released November dealer sales statistics. While sales show growth in every location around the world and in every business segment, the problem is that the growth in November was the slowest the company has experienced all year in most areas it does business. Worldwide sales grew 5% -- the slowest rate all year, while the highest was back in January, when the company realized a 27% growth rate. The Asia-Pacific market grew 2%; the Europe, Africa and Middle East market grew 3%; and the U.S. market grew 3%. Latin America spiked 15%, its highest rate all year and one of the few regions that grew faster than in previous months.

Shares of Intel are trading lower by 0.6% after the company was downgraded by an analyst at Evercore Partners. Analyst Patrick Wang lowered his estimates for Intel's fourth-quarter revenue from $13.6 billion to $13.4 billion and dropped the profits from $0.46 per share to $0.44. He also reduced his 2013 full-year revenue estimates from $54 billion to $53.4 billion and revised full-year EPS from $1.90 per share down to $1.85. Wang believes the struggling PC market will continue limping along in 2013, which would affect the chip makers like Intel.

When it comes to dominating markets, it doesn't get much better than Intel's position in the PC microprocessor arena. However, as many analysts have noted, that market is maturing, and Intel will find itself in a precarious situation if it doesn't find new avenues for growth. In this premium research report on Intel, our analyst runs through all of the key topics investors should understand about the chip giant. Better yet, you'll continue to receive updates for an entire year. Click here now to learn more.


Read/Post Comments (0) | Recommend This Article (4)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2164236, ~/Articles/ArticleHandler.aspx, 7/25/2014 9:20:22 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement